The future of diabetes drugs is one where efficacy is matched with patient-centric solutions, ensuring that treatments are not only effective but also seamlessly integrated into daily life
Saito T, Iwata N, Tsubuki S et al (2005) Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation
Early phase II studies in older adults with sarcopenia showed increases in lean mass and, in slower walkers, improvements in gait speed and 6-minute walk distance [62]
I had extreme fatigue, which was so overwhelming, the wife and mother of four said
Give us a call and we will make sure to accommodate you at the earliest
doi: 10.1016/j.autneu.2003.11.001 163 VahlTPTauchiMDurlerTSElfersEEFernandesTMBitnerRDet al